Why a Biotech Fund Opened a New $6 Million Place in Vir Amid a 99% Inventory Rally
Superstring Capital Administration disclosed a brand new place in Vir Biotechnology (NASDAQ:VIR)buying 730,548 shares within the first quarter. The estimated transaction worth was $5.82 million...